Dr. Barbara Schmidt

Dr. Barbara Schmidt, a professor at McMaster University and a pioneer in neonatology, discusses critical advancements in neonatal research. She highlights the necessity of long-term follow-up for high-risk infants and critiques adaptive trial designs. Dr. Schmidt explores the expanding role of caffeine therapy, emphasizing its potential benefits beyond its traditional use. The conversation underscores the importance of evidence-based practices in improving outcomes for newborns and the value of in-person collaboration in the medical community.